TR201905336T4 - Rekombinant rsv antijenleri. - Google Patents

Rekombinant rsv antijenleri. Download PDF

Info

Publication number
TR201905336T4
TR201905336T4 TR2019/05336T TR201905336T TR201905336T4 TR 201905336 T4 TR201905336 T4 TR 201905336T4 TR 2019/05336 T TR2019/05336 T TR 2019/05336T TR 201905336 T TR201905336 T TR 201905336T TR 201905336 T4 TR201905336 T4 TR 201905336T4
Authority
TR
Turkey
Prior art keywords
recombinant rsv
rsv antigens
antigens
rsv
recombinant
Prior art date
Application number
TR2019/05336T
Other languages
English (en)
Inventor
Baudoux Jean-Pierre
Blais Normand
Rheault Patrick
Ruelle Jean-Loius
Original Assignee
Glaxosmithkline Biologicals Sa
Id Biomedical Corp Quebec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biologicals Sa, Id Biomedical Corp Quebec filed Critical Glaxosmithkline Biologicals Sa
Publication of TR201905336T4 publication Critical patent/TR201905336T4/tr

Links

Abstract

Bu açıklama, rekombinant respiratuar sinsitiyal virüs (RSV) antijenleri ve immünolojik kompozisyonlar (örn. aşılar) dahil bunların yapılmasına ve RSV enfeksiyonunun tedavisi ve/veya önlenmesi amaçlı kullanılmasına yönelik yöntemler sunar.
TR2019/05336T 2008-05-27 2008-12-23 Rekombinant rsv antijenleri. TR201905336T4 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1652408P 2008-05-27 2008-05-27
US5620608P 2008-05-27 2008-05-27

Publications (1)

Publication Number Publication Date
TR201905336T4 true TR201905336T4 (tr) 2019-05-21

Family

ID=67953949

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/05336T TR201905336T4 (tr) 2008-05-27 2008-12-23 Rekombinant rsv antijenleri.

Country Status (1)

Country Link
TR (1) TR201905336T4 (tr)

Similar Documents

Publication Publication Date Title
CY1117673T1 (el) Ανασυνδυασμενα αντιγονα rsv
EA201070794A1 (ru) Рекомбинантные антигены rsv
CY1123152T1 (el) Τροποποιημενες πρωτεϊνες rsv f και μεθοδοι χρησης τους
CY1121600T1 (el) Σταθεροποιημενα διαλυτα πολυπεπτιδια rsv f προσυντηξης
CY1119284T1 (el) ΣΩΜΑΤΙΔΙΑ ΠΑΡΟΜΟΙΑ ΜΕ ΙΟ ΓΛΥΚΟ-ΠΡΩΤΕΪΝΗΣ ΛΥΣΣΑΣ (VLPs)
GEP20217260B (en) Antibody neutralizing human respiratory syncytial virus
PH12015502735A1 (en) Stabilized soluble pre-fusion rsv f polypeptides
PH12018501962A1 (en) Stablizied soluble pre-fusion rsv f proteins
EA201890235A1 (ru) Стабилизированные растворимые f-полипептиды rsv до слияния
MY169331A (en) Vaccine against rsv
EA201391515A1 (ru) Инактивированная вакцина вируса денге
JOP20210106A1 (ar) بروتينات rsv f سابقة الاندماج مستقرة
TN2011000182A1 (en) Live, attentuated respiratory syncytial virus
MY194419A (en) Stabilized pre-fusion rsv f proteins
GB201019240D0 (en) Respiratory syncytical virus vaccine
ATE549031T1 (de) Impfstoffzusammensetzung zur prävention von cmv- infektionen
TR201905336T4 (tr) Rekombinant rsv antijenleri.
WO2011041350A3 (en) Xenotropic mulv-related virus (xmrv) compositions and methods of use
PH12014502086A1 (en) Vaccine against rsv